Skip to main content
Premium Trial:

Request an Annual Quote

Taking the Conflict-of-Interest Heat

University of Wisconsin-Madison cancer researcher Minesh Mehta has resigned his post after the school started investigating a possible conflict of interest in his dealings with a device maker, the Wisconsin State Journal's Doug Erickson reports. In April, UW starting looking into Mehta's relationship with TomoTherapy, which makes cancer treatment devices. For almost 10 years, Erickson says, Mehta has been the lead researcher on a clinical trial for a specialized radiation treatment for cancer patients — the device used in the majority of the study is made by TomoTherapy, for which Mehta is a consultant. Mehta, who turned in his resignation in May, says there is no conflict of interest and that the investigation had nothing to do with why he resigned, although he did so without having lined up another job. In 2009, Erickson says, TomoTherapy paid Mehta more than $20,000 in compensation and more than $10,000 in stock options for about 20 days of consulting work.

HT: The Chronicle of Higher Education

The Scan

Ancient Greek Army Ancestry Highlights Mercenary Role in Historical Migrations

By profiling genomic patterns in 5th century samples from in and around Himera, researchers saw diverse ancestry in Greek army representatives in the region, as they report in PNAS.

Estonian Biobank Team Digs into Results Return Strategies, Experiences

Researchers in the European Journal of Human Genetics outline a procedure developed for individual return of results for the population biobank, along with participant experiences conveyed in survey data.

Rare Recessive Disease Insights Found in Individual Genomes

Researchers predict in Genome Medicine cross-population deletions and autosomal recessive disease impacts by analyzing recurrent nonallelic homologous recombination-related deletions.

Genetic Tests Lead to Potential Prognostic Variants in Dutch Children With Dilated Cardiomyopathy

Researchers in Circulation: Genomic and Precision Medicine found that the presence of pathogenic or likely pathogenic variants was linked to increased risk of death and poorer outcomes in children with pediatric dilated cardiomyopathy.